ARCHIVE

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  February 28, 2005

• Daiichi Suntory Transfer Sales of Farom to Maruho
  February 28, 2005

• Meet the Leaders (40)
  February 28, 2005

• BUSINESS NEWS IN BRIEF
  February 28, 2005

• Sunrise Plan Aims at Sales of \360 Billion in 2010: Mr Nagayama of Chugai
  February 28, 2005

• Transitional Period for Labeling Changes in Rx-only Drug Announced
  February 28, 2005

• Korosho Issues Guide on Preparing Manufacturing Applications
  February 28, 2005

• Drug Production Statistics Data to Be Reported More Promptly
  February 28, 2005

• 2005 Will Be a Major Turning Point: Prefectural Health Officials Meeting
  February 28, 2005

• Korosho Calls For Reimbursement of Self-Injection of IFNa, Etanercept
  February 28, 2005

• Cumulative Deaths in Rheumatrex-treated Patients Reach 134: Wyeth
  February 28, 2005

• REGULATORY NEWS IN BRIEF
  February 28, 2005

• Sankyo, Daiichi Reportedly to Consolidate This October
  February 28, 2005

• Tapered Injection Needle Reduces Pain for Diabetics: Novo Nordisk
  February 28, 2005

• 2/3 of Ethical Drugs Designated as "Rx-only Drugs"
  February 21, 2005

• Korosho to Demand PIII Data in NDA for Anticancer Agents
  February 21, 2005

• Handling of Applications for Add'l Indications of Anticancer Drugs Notified
  February 21, 2005

• Add. Indications Approved for 45 Drugs Used Off-label: JAPIC Seminar
  February 21, 2005

• REGULATORY NEWS IN BRIEF
  February 21, 2005

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  February 21, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 480
• 481
• 482
• 483
• 484
• 485
• 486
• 487
• 488
• …
• Next ›
• 最終 »